BioPharm International, February 2022

Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates.

A rich clinical pipeline of regenerative medicine product candidates bodes well for a robust future.

The growing use of automation and digitalization technologies push cell culture bioprocessing forward.

The need for sustainability and early considerations of a lyophilization strategy grow more pertinent on the back of growing biologics volume.

Lighthouse manufacturing techniques utilize technology and automation to streamline production.

Build into the chemistry, manufacturing, and control strategy the ability to pivot and be flexible should the course change.

Recently released technologies aim to improve laboratory processes.

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, details regulatory requirements for developing a quality manual.

Innovations aid efficient processing.

Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.

Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.

The global nature of the COVID-19 pandemic emphasizes the critical importance of expanded vaccination.

The process of reshaping inevitably leads to fresh insights.

The MicroEDS BioWaste Treatment System can process between 150 to 500 L of waster per day.

The 3M Harvest RC clarifier condenses three process steps into a single-stage purification of recombinant protein therapeutics.

The GEA kytero combines the high performance of larger GEA stainless-steel pharmaceutical centrifuges with the benefits offered by disposable components.

STERIS Life Sciences’ VestaSyde SQ 64 st Ready-to-Use Disinfectant Wipes are part of a family of products designed to disinfect cleanroom services.

Busy is good for business.